Delphi Genetics Competitors and Similar CompaniesClear all
Delphi Genetics's competitors and similar companies include Kolon TissueGene, OXGENE and ZIOPHARM Oncology.
 Delphi Genetics Delphi Genetics is a company that specializes in bioproduction of plasmid DNA and recombinant proteins including antibodies. |  Kolon TissueGene Kolon TissueGene is a company developing cell therapies to target various orthopedic diseases and degenerative disorders. |  ZIOPHARM Oncology ZIOPHARM Oncology is an American biopharmaceutical company developing novel therapeutics for the treatment of cancer. | ||
Founding Date | Founding Date 2001 | Founding Date 1999 | Founding Date 2011 | Founding Date 2005 |
Type | Type Private | Type Private | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Charleroi, BE HQ | Locations Rockville, US HQ | Locations Oxford, GB HQ | Locations Boston, US HQ |
Employees | Employees 910% decrease | Employees 615% increase | Employees 264% increase | Employees 7352% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) £1m (FY, 2018) | Revenue (est.) $5k (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income (£2.7m) (FY, 2018) | Net income ($4.2m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Kolon TissueGene
HQ
Rockville, US
Employees
61↑ 5% increase
Kolon TissueGene is a company developing cell therapies to target various orthopedic diseases and degenerative disorders.
View company
OXGENE
HQ
Oxford, GB
OXGENE (also known as Oxford Genetics) is a synthetic biology company.
View companyZIOPHARM Oncology
HQ
Boston, US
Employees
73
ZIOPHARM Oncology is an American biopharmaceutical company developing novel therapeutics for the treatment of cancer.
View company